“Existing vaccines have shown that they continue to be effective against mutations circulating in Europe,” said Emer Kook, Executive Director of the European Medicines Agency, speaking to the European Parliament’s Committee on the Environment, Public Health and Food Safety.
“It is very important that we emphasize that we are prepared. We know that viruses mutate. “We know that at some point there will be a mutation that means we need to change the current approach.”
She added that “existing vaccines have shown that they continue to be effective against the variants circulating in Europe”.
At the same time, he noted that it is not known at this time whether this will continue with the Omicron mutation and that a procedure will be needed, the “cross-vaccination neutralization”, which takes about two weeks.
“The lab is being tested to see if existing vaccines provide protection against the new mutation,” said Cook.
The head of Coreper stressed that there are many factors that need to be taken into account, such as the fact that there is a large number of vaccinated adults in Europe.
“There are a lot of factors going on right now that could have an impact on the transmission of the Omicron mutation in Europe,” he said.
“At the same time, we need to be prepared in case we need to change what we have
Follow Skai.gr on Google News
and be the first to know all the news
.
